Newsletters

32 Pear patents. Amwell $644M IPO.

9.11.20

6 min. Read

New Teladongo merger details. Pear’s acquisitive study strategy.

9.04.20

8 min. Read

Will Amazon ruin voice biomarkers? Amwell S-1 insights.

8.28.20

8 min. Read

20 percent of Rx-only digital therapeutics have studies so far.

8.14.20

9 min. Read

Nine thoughts on Teladongo. CPT sneak peek.

8.07.20

8 min. Read

Hinge plans virtual MSK clinic. Livongo upping focus on DPP?

7.31.20

5 min. Read

Livongo’s IPO anniversary. DTx pipelines.

7.24.20

7 min. Read

Two UnitedHealth behavioral health acquisitions. BMS DTx launch Q3.

7.17.20

7 min. Read

265 PPP loans for digital health. Orexo Modia?

7.10.20

6 min. Read

What Otsuka bid for Proteus. Important DTx study begins.

7.01.20

6 min. Read